ADR AC GmbH ^Companies

ADR-AC has longtime expertise in drug hypersensitivity research. In case of adverse drug reactions during pre-clinical stages, phase I - III clinical trials or in post-marketing stages, ADR-AC offers defined risk assessment to analyze and evaluate the immune-stimulatory potential of culprit substances. Our know-how in the field of small chemical molecules as well as biologicals, eg therapeutic proteins and monoclonal antibodies. ADR-AC has profound expertise in performing in vitro experiments based on human immune cells. Upon your request ADR-AC will propose a panel of tests designed to reveal the immunogenic potential of your drug.